Are you currently dealing with HPV (Human Papillomavirus)?
Did you know that there may be a link between people with immunosuppression diseases like HPV and new class of mutation, including the KRAS-variant?
You may be eligible for one of several studies about these mutations, which seek to find the best ways to identify the link between these disorders and these mutations.
TAKE THE ELIGIBILITY SURVEY
We encourage you to see if you are eligible to join a MiraKind study to help us discover meaningful ways to better treat patients with genetic mutations. If you would like to join a study, please click the button below. You will be able to choose to get your KRAS-variant results at a discounted cost ($195) through the study. If you would prefer to directly order KRAS-variant testing at cost ($295) without joining a study, please follow this link.